Growth Hormone Deficiency clinical trials

Explore recruiting growth hormone deficiency clinical trials.

Recruiting growth hormone deficiency studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Growth Hormone Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A trial comparing the effect and safety of once weekly dosing of somapacitan with daily Norditropin® in children with growth hormone deficiency

Germany, Italy, Spain, Slovenia, Poland, Austria +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults

Netherlands, France, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

An Extension Study to Monitor Long-Term Safety of LUM-201 Treatment in Children with Idiopathic Growth Hormone Deficiency

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin® (somatropin) Delivery and Taken Up Into the Blood in Healthy Adults

Belgium

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM 201 in Naïve-to-Treatment, Prepubertal Children with Growth Hormone Deficiency (GHD)

Romania, France, Italy, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

The Growth Hormone Deficiency Reversal Trial: Effect on final height of discontinuation vs continuation of growth hormone treatment in pubertal children with isolated growth hormone deficiency – A non-inferiority randomised controlled trial

Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Growth Hormone Deficiency trials by city

Growth Hormone Deficiency in Toronto Growth Hormone Deficiency in Vancouver Growth Hormone Deficiency in Montreal Growth Hormone Deficiency in Calgary Growth Hormone Deficiency in Edmonton Growth Hormone Deficiency in Ottawa Growth Hormone Deficiency in Winnipeg Growth Hormone Deficiency in Quebec City Growth Hormone Deficiency in Hamilton Growth Hormone Deficiency in Kitchener Growth Hormone Deficiency in London Growth Hormone Deficiency in Halifax Growth Hormone Deficiency in New York Growth Hormone Deficiency in Los Angeles Growth Hormone Deficiency in Chicago Growth Hormone Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease